这种特效药可能比疫苗更快？君实生物新冠中和抗体计划第二季度进入临床
May 20, 2020 13:24 HKT | |
|
Agilex Biolabs Presents the Australian Advantage, including the World's Largest Rebate on Clinical Trial Spend, at BIO Korea 2020
May 20, 2020 16:00 HKT |  |
|
經申辦方推選，Novotech 榮獲“CRO 領導力大獎”
May 20, 2020 11:00 HKT |  |
|
经申办方推选，Novotech 荣获“CRO 领导力大奖”
May 20, 2020 11:00 HKT | |
|
中国生物制药与康方生物共同开发派安普利单抗联合安罗替尼一线治疗晚期肝癌的临床试验数据获ASCO年会接受呈列
May 19, 2020 17:51 HKT |  |
|
中國生物製藥與康方生物共同開發派安普利單抗聯合安羅替尼一線治療晚期肝癌的臨床試驗數據獲ASCO年會接受呈列
May 19, 2020 17:50 HKT | |
|
Results from Clinical Trials of Penpulimab in Combination with Anlotinib for 1L HCC Co-developed by Sino Biopharmaceutical and Akeso Accepted for Presentation at ASCO Annual Meeting
May 19, 2020 17:50 HKT | |
|
开拓药业即将挂牌 明星基石保驾护航
May 18, 2020 16:11 HKT | |
|
開拓藥業即將掛牌 明星基石保駕護航
May 18, 2020 16:10 HKT | |
|
生物科技股被市场热捧，核心股票如何拣选？
May 11, 2020 11:08 HKT | |
|
生物科技股被市場熱捧，核心股票如何揀選？
May 11, 2020 11:07 HKT | |
|
Cyber Company to Supply 50M Health "COVI-PASS(TM)"
May 08, 2020 14:30 HKT |  |
|
商业化变现在即 开拓药业核心产品优势明显
May 08, 2020 10:12 HKT | |
|
商業化變現在即 開拓藥業核心產品優勢明顯
May 08, 2020 10:11 HKT | |
|
Novotech COVID-19 Clinical Trial Clients Benefit from New Asia-Pacific Fast-Track Review Processes
Apr 28, 2020 19:00 HKT | |
|
华领医药宣布Dorzagliatin与恩格列净（一种SGLT-2抑制剂）联合用药临床研究的成功结果
Apr 27, 2020 09:53 HKT | |
|
華領醫藥宣佈Dorzagliatin與恩格列淨（一種SGLT-2抑制劑）聯合用藥臨床研究的成功結果
Apr 27, 2020 09:51 HKT | |
|
Hua Medicine Announces Positive Results in the Combination Study of Dorzagliatin with Empagliflozin (a SGLT-2 inhibitor)
Apr 27, 2020 09:50 HKT | |
|
研发强劲无惧竞争 康方生物后发制人底气足
Apr 24, 2020 18:21 HKT | |
|
研發強勁無懼競爭 康方生物後發制人底氣足
Apr 24, 2020 18:20 HKT | |
|